July 18, 2010
For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.
This AIDS 2010 satellite features expert discussion on recent progress and future directions in HIV vaccine research and development. The session will include a review of the last 25 years of HIV vaccine research and development; a panel discussion on the progress that's been made including discussions on next steps following the RV144 Thai prime-boost study results and in developing the next generation of vaccine candidates for testing; an update on the Global HIV Vaccine Enterprise Scientific Strategic Plan for the field; and a panel discussion on the way forward, which will consider some of the cross-cutting considerations such as industry engagement, developing world infrastructure, community engagement, opportunities for young and early-career investigators, mobilizing resources and building clinical trial and regulatory capacity.
The Search for an HIV Vaccine: Where Are We, Where Are We Going, and How Can We Get There Faster?
25 Years of HIV Vaccine Research: What Have We Accomplished?
Panel Discussion: Progress Toward an HIV Vaccine
A Roadmap for Speeding and Improving HIV Vaccine Research: The Global HIV Vaccine Enterprise 2010 Scientific Strategic Plan
Panel Discussion: The Way Forward
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view all of Kaiser's coverage of the XVIII International AIDS Conference at http://www.kff.org/aids2010. © Henry J. Kaiser Family Foundation. All rights reserved.
No comments have been made.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|